Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent

İlker Devrim1, Mustafa Taha Özkul2, İlknur Çağlar3

  • 1Department of Pediatric Infectious Diseases, Dr. Behçet Uz Children's Hospital, İzmir, Turkey. ilkerdevrim2003@yahoo.com.

Insights

Implementing central line bundles significantly reduced central line-associated bloodstream infections (CLABSI) and associated costs in pediatric cancer patients. The program proved cost-effective, with savings from prevented infections exceeding implementation expenses.

Area of Science:

  • Pediatric Oncology
  • Healthcare Economics
  • Infection Control

Background:

  • Central line bundles effectively reduce central line-associated bloodstream infections (CLABSI) in pediatric cancer patients with ports.
  • Limited cost-effectiveness data exists for these programs in pediatric oncology, with most studies focusing on adult or ICU populations.

Purpose of the Study:

  • To assess the cost-effectiveness of central line bundle programs in reducing CLABSI in pediatric cancer patients.
  • To analyze healthcare costs associated with CLABSI before and after bundle implementation.

Main Methods:

  • A 6-year cross-sectional study was conducted in a pediatric hematology-oncology ward.
  • Total healthcare costs attributable to CLABSI in patients with ports were comprehensively assessed over two distinct periods.

Main Results:

  • CLABSI rates decreased significantly from 8.31 to 3.04 per 1000 central line days (p < 0.001).
  • Total attributable costs for CLABSI decreased from $130,661 in the pre-bundle period to $116,579 in the bundle period.
  • The implementation of central line bundles prevented 71 CLABSIs, resulting in an additional cost saving of $208,977.

Conclusions:

  • Central line bundles effectively decrease both CLABSI rates and associated healthcare expenditures.
  • The cost of implementing bundle elements was offset by the savings generated from preventing high-cost CLABSIs.
Abstract